Trial intelligence / Profile preview

Nano-Silver Nitrate vs Silver Nitrate for BLVR in Emphysema

NCT06629558Recruiting

Sponsor
Mansoura University Hospital
Start
Oct 2024
Primary completion
Dec 2025
Modality
Nanoparticles, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of nano-silver nitrate in emphysema (2 arms), sponsored by Mansoura University Hospital. Primary endpoints: Residual Volume/Total Lung Capacity Ratio at 6 months, Forced Expiratory Volume in 1 Second at 6 months and 3 more. Started Oct 2024; status: recruiting.

02

Drugs

nano-silver nitrate
03

Conditions

emphysema

Beyond the preview

Go deeper on NCT06629558.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06629558.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call